Pharmacokinetics, Bioavailability, & Bioequivalence
This section features pharmacokinetic studies conducted to assess the bioavailability of newly developed drugs and/or alternative formulations (eg, tablets vs capsules, extended release vs immediate release), or the bioequivalence of generic and branded pharmaceuticals or alternative formulations, often for the purposes of marketing authorization. Manuscripts from industry or academia and featuring studies in healthy volunteers of both sexes are encouraged. Studies must comply with the requirements of the US Food and Drug Administration, European Medicines Agency, or other corresponding regulatory agencies. Because of the rapid publication process, time-sensitive topics are of particular interest. All manuscripts are peer reviewed for clinical relevance, technical accuracy, clarity, and objectivity.
Download Tips for Submitting Bioequivalence Studies for manuscript preparation instructions.
